NASDAQ$PCT
PureCycle Technologies Inc · Q2 2025 earnings
Q2 2025 earnings · · After market close · Investor relations
Briefing
PureCycle Technologies reported Q2 2025, revenue of $1.6M, a net loss of $144.2M.
For Q2 2025, PureCycle Technologies reported Revenue was $1.6M; net loss was $144.2M. Management discusses operating trends, liquidity, capital priorities, and sector risks in the quarterly filing.
- Revenue $1.6M.
- Net loss $144.2M.
- PureCycle Technologies MD&A highlights liquidity, capital, and core operating trends.
- Macro and competitive factors shape year-over-year comparisons.
Headline financials
Revenue & EPS history
PureCycle · Revenue · Quarterly
$1.65M
Forward guidance
PureCycle Technologies focuses on clinical milestones, funding runway, and pipeline progress in MD&A.
Tailwinds
- Pipeline advancement and trial readouts.
- Cash runway supports ongoing R&D.
- Partnership or licensing optionality.
Headwinds
- Trial timing and regulatory uncertainty.
- Funding needs and potential dilution.
- Pre-revenue or early commercial stage limits near-term profitability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2025
+2.6%
Avg return
Earnings day
+3.2%
Avg return
5 days after
+11.4%
Avg return
30 days after
54%
13 / 24 earnings
Positive
+44.1%
Q4 2022
Best reaction
-22.3%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.4% | +29.2% | +63.7% | |
| Q4 2025 | -22.3% | -23.6% | -35.0% | |
| Q3 2025 | +9.9% | -0.1% | -3.3% | |
| Q2 2025 | +0.2% | +9.9% | +8.4% | |
| Q1 2025 | +15.1% | +20.9% | +50.6% | |
| Q4 2024 | -2.6% | -3.7% | -25.9% | |
| Q3 2024 | -10.5% | -5.2% | -1.3% | |
| Q1 2024 | -7.7% | -6.4% | +5.2% | |
| Q4 2023 | -17.1% | -15.1% | -6.0% | |
| Q3 2023 | -9.9% | -18.4% | +12.8% | |
| Q2 2023 | -5.0% | +3.5% | -21.8% | |
| Q1 2023 | +4.6% | -5.1% | +8.9% | |
| Q4 2022 | +44.1% | +21.8% | +32.2% | |
| Q3 2022 | -11.2% | -14.0% | -20.0% | |
| Q2 2022 | +14.7% | +15.4% | +9.7% | |
| Q1 2022 | +30.3% | +36.9% | +41.2% | |
| Q4 2021 | +11.6% | +8.4% | -5.2% | |
| Q3 2021 | -19.9% | -11.1% | -9.2% | |
| Q3 2020 | -19.9% | -11.1% | -9.2% | |
| Q2 2021 | +1.1% | -11.6% | -12.2% | |
| Q2 2020 | +1.1% | -11.6% | -12.2% | |
| Q1 2021 | +18.4% | +22.6% | +67.3% | |
| Q4 2020 | +18.4% | +22.6% | +67.3% | |
| Q1 2020 | +18.4% | +22.6% | +67.3% | |
| Q4 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro